Recently Listed Stock Crashes 15% After Reporting 61% QoQ Decrease in Net Profit

Synopsis: Gaudium IVF shares dropped 15% after reporting a 61% QoQ fall in profit, despite strong YoY revenue growth. While expansion and rising demand for fertility services support long-term prospects, weak sequential performance and margin pressure have weighed on investor sentiment in the near term.

The stocks of Gaudium IVF and Women Health Limited faced pressure as the company witnessed declining sequential profitability. Although the company continues to grow its footprint and gain from the increasing need for fertility treatments, the decline in profitability has brought the spotlight on efficiency.

With a market cap of Rs 610 crore, the shares of Gaudium IVF and Women Health Ltd crashed about 15% in today’s trading session and reached a low of Rs 80.15. When compared to its previous day’s closing price of Rs 94.60. The shares are trading at a PE of 31.2, whereas their industry’s PE is at 35.3.

Q3 FY26 Results Highlights 

The revenue from operations for the company stood at Rs 24.51 crore when compared to Rs 14.42 crore in Q3 FY25, up by about 70 per cent on a YoY basis and, on a QoQ basis, down by 23 per cent from Rs 31.73 crore in Q2 FY25.

When it comes to profitability, the company has gone from an Rs 3.4 crore profit in Q3 FY25 to an Rs 3.63 crore profit in Q3 FY26, up 7% YoY, and from Rs 9.38 crore in Q2 FY26, down about 61% QoQ. 

Company Overview

Gaudium IVF and Women Health Limited, incorporated in 2015, has carved a niche as a rising player in the fertility treatment industry in India, employing a hub-and-spoke strategy. The company has expanded its footprint across India, with more than 30 locations, including seven hubs and multiple spokes, across prominent geographies like Delhi, Mumbai, Bengaluru, Patna, and others. 

Strategic partnerships with experts specialising in infertility have helped the company spread awareness about assisted reproductive technology, thereby increasing the overall reach of its services, including the international market, the US, the UK, Africa, and more.

The company provides a wide range of fertility and women’s health care services, including IVF, ICSI, IUI, ovulation induction, and more, thereby addressing all types of infertility issues faced by both men and women. It also provides specialised care for conditions like PCOS, endometriosis, high-risk pregnancies, and more. 

Moreover, the company’s focus on providing the best treatments for conditions like male infertility ensures the company benefits from the increasing fertility industry, both domestically and globally.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Recently Listed Stock Crashes 15% After Reporting 61% QoQ Decrease in Net Profit appeared first on Trade Brains.